本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

2.94
-0.2100-6.67%
盤前2.950.0095+0.32%06:46 EDT
成交量:1,928.74萬
成交額:5,740.59萬
市值:15.51億
市盈率:-2.04
高:3.12
開:3.09
低:2.91
收:3.15
52周最高:7.18
52周最低:2.91
股本:5.27億
流通股本:4.15億
量比:1.30
換手率:4.65%
股息:- -
股息率:- -
每股收益(TTM):-1.4410
每股收益(LYR):-1.4410
淨資產收益率:-59.54%
總資產收益率:-27.72%
市淨率:1.37
市盈率(LYR):-2.04

資料載入中...

2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

重要事件披露

Form 8-K - Current report
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities